Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Therapix Biosciences Ltd (TRPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,865
  • Shares Outstanding, K 3,500
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,240 K
  • 36-Month Beta 1.39
  • Price/Sales N/A
  • Price/Cash Flow 1.91
  • Price/Book 1.84

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +16.67%
on 07/16/18
4.50 -22.22%
on 07/11/18
-0.85 (-19.54%)
since 06/19/18
3-Month
3.00 +16.67%
on 07/16/18
4.94 -29.15%
on 04/23/18
-1.34 (-27.69%)
since 04/19/18
52-Week
3.00 +16.67%
on 07/16/18
7.69 -54.49%
on 04/09/18
-3.06 (-46.65%)
since 07/19/17

Most Recent Stories

More News
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Studies for its Drug Candidate THX-160 for Treatment of Pain

Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its pre-clinical...

TRPX : 3.50 (+3.24%)
THXBY : 4.0100 (unch)
Therapix Biosciences Signs Term Sheet for the Transfer of Non-Pain Cannabinoid-Based Drug Pipeline Assets to Cure Pharmaceutical

Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix") a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that today that it has signed...

TRPX : 3.50 (+3.24%)
CURR : 1.7700 (+26.88%)
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.

CURE Pharmaceutical (OTCQB:CURR), ("CURE"), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix Biosciences Ltd. (Nasdaq:TRPX), ("Therapix"),...

TRPX : 3.50 (+3.24%)
CURR : 1.7700 (+26.88%)
Legal Supply Channels are Expected to Show Big Growth in Cannabis Markets

According to a report by Ameri Research Inc., the global legal cannabis market was valued at USD 14.3 Billion in 2016 and is projected to grow at a CAGR of 21.1% between 2017 and 2024, while also reaching...

NTEC : 4.75 (+4.40%)
TRPX : 3.50 (+3.24%)
CRON : 6.83 (+0.74%)
AXIM : 2.5400 (-0.39%)
WDDMF : 1.1279 (-0.19%)
WMD.VN : 1.500 (+0.67%)
Therapix Biosciences Updates Regarding TASE Delisting

Therapix Biosciences Ltd. (Nasdaq: TRPX) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, provides updates and dates in connection with the...

TRPX : 3.50 (+3.24%)
Cannabis' Economic Impact to Expand With Emerging Markets

According to a research report provided by Marijuana Business Daily, cannabis retail sales continue to grow year-over-year as new markets emerge and more states legalize medical and recreational cannabis....

NTEC : 4.75 (+4.40%)
TRPX : 3.50 (+3.24%)
CRON : 6.83 (+0.74%)
RVV.VN : 0.195 (+8.33%)
AXIM : 2.5400 (-0.39%)
WDDMF : 1.1279 (-0.19%)
WMD.VN : 1.500 (+0.67%)
RVVTF : 0.1370 (-2.56%)
Therapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette Syndrome

Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix" or the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announces sponsorship...

TRPX : 3.50 (+3.24%)
Therapix Biosciences Announces Enrollment of the First Patient for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep Apnea Using Cannabinoid-based Drug

Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix" or the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on...

TRPX : 3.50 (+3.24%)
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update

Therapix Biosciences Ltd. (Nasdaq: TRPX) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, issued today its financial summary - first quarter...

TRPX : 3.50 (+3.24%)
CURR : 1.7700 (+26.88%)
Biomica, Evogene's Newly Established Subsidiary, Announces Therapeutic Areas of Focus

Biomica, a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology...

TRPX : 3.50 (+3.24%)
EVGN : 2.90 (+0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade TRPX with:

Business Summary

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to...

See More

Key Turning Points

2nd Resistance Point 3.70
1st Resistance Point 3.60
Last Price 3.50
1st Support Level 3.30
2nd Support Level 3.10

See More

52-Week High 7.69
Fibonacci 61.8% 5.90
Fibonacci 50% 5.35
Fibonacci 38.2% 4.79
Last Price 3.50
52-Week Low 3.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar